[ad_1]
WWhat else? What is still supposed to happen? After the panic and chatter reactions to the mutant virus VUI-202012/01, you must ask yourself the question that the world finds a healthy balance between extremes. Hysteria doesn’t help anyone, but minimizing it is even less effective. Least of all the most vulnerable. Danger didn’t just hit the world with the new variant. And the danger has not passed, because governments react with flight bans and border closures.
Based on all that is available in terms of epidemiological data, the coronavirus mutant, which was first detected in the south of England, has been circulating for months. It’s only now been noticed because Britain, unlike most other countries, including Germany, has established an effective network for the genetic registration of Sars-CoV-2 isolates from patient samples. If you don’t look, you won’t find anything, this lesson will make sense to everyone after long discussions about virus testing and the number of cases. That would be a good approach for a “coordinated European” response. The information that this research network has provided about the mutant so far is quite a lot, but still very little and generally uncertain. There is “moderate confidence” in their own assessment, this is how the scientists reported their earlier findings to the British government, which has created its own task force and reported to the World Health Organization.
These more than a dozen changes could have systemic relevance
But what does that mean: moderate confidence? The results available to date are said to be incomplete and the data required for a final safety assessment is still lacking. One thing is clear: a mutant with many different mutations, of all things in the spike protein that is crucial for infection, is unusual and must also be taken seriously. In other words, these more than a dozen changes could have systemic relevance. In some experiments these changes have already shown that growth in cell culture increases and therefore the multiplication of the virus. The mutant apparently multiplies faster in the artificial system of a laboratory and produces more virus particles. At the same time, the mutant also contains “debilitating” traits that could affect the virus’s ability to bind to human cells.